|
Federal regulations require that protocols be renewed no less frequently
than annually.
The IRB is required to decide when a protocol needs continuing review
at the time of the original approval and of each subsequent renewal. Factors
for making the decision about the frequency of review include the level
of risk, location of the study, and any other factors that might affect
the welfare of the subjects.
When an original protocol or renewal application is approved, investigators
will be notified of the date upon which the protocol must be renewed again.
The IRB's database is designed to generate reminder notices as renewal
dates approach.
There is no limit on the number of renewals that may be approved for a
project. However, the IRB reserves the right to request that a new protocol
be prepared if changes are extensive.
Renewals of protocols that were reviewed through expedited procedures,
may be expedited under the following circumstances.
- There are no proposed changes.
- Proposed changes are minor.
Renewals of protocols that required full review may be expedited under the
following circumstances:
- The research is permanently closed to the enrollment of new subjects;
all subjects have completed all research related interventions; and
the research remains active only for long-term follow-up of subjects.
- No subjects have been enrolled and no additional risks have been identified.
- The remaining research activities are limited to data analysis.
- The IRB determined and documented at a convened meeting that the research
involves no greater than minimal risk and no additional risks have been
identified. (This scenario could occur if a protocol required full review
due to the risk of coercion. If the possibility of coercion was removed
and if additional risks were minimal, the IRB could document in its
minutes that there are no greater than minimal risks to subjects, thus
paving the way for expedited review of renewals.)
Under all other circumstances, if the original protocol required full
review, the continuing review must
be conducted by the full committee, even if there are no changes or if
proposed changes are minor.
The rationale for this requirement is that if a full review was required
the protocol either used a vulnerable subject population or involved more
than minimal risk to the subjects. These protocols should be revisited
even if the investigator does not propose to change the protocol. The
progress report, together with the results of other new research, may
indicate that the risk/benefit balance has shifted. Or, new research about
how subjects understand consent forms, may require that the forms currently
in use be modified.
The Office for Human Research Protections (federal) has provided guidance
about what elements need to be considered in a continuing review in order
to make the review meaningful. The elements are:
- The number of subjects accrued.
- The number of subjects anticipated for the renewal period.
- A copy of the current consent document.
- A summary of progress to date.
- For research with more than minimal risk, or research that provides
and evaluates behavioral or psychological interventions, a summary of
recent literature related to the research topic. Federal policy requires
that investigators inform subjects of important new information that
might affect their willingness to participate in the research. This
information may be findings of this research or of that carried out
by others.
- A description of any adverse events or unanticipated problems involving
risks to subjects and proposed solutions, any withdrawal of subjects
from the research, or complaints about the research. Adverse events
include reporting of suspected child abuse to NC authorities.
The federal Office of Human Research Protections recognizes the logistical
advantages of keeping the IRB approval period constant from year to year
throughout the life of each project. Therefore, when a continuing review
(expedited or full) takes place within 30 days before an approval period
expires, the protocol may retain its anniversary date.
Continuing reviews must be reviewed and approved on before the expiration
date of the current approval period of a protocol.
The regulations make no provision for any grace period extending the
conduct of research beyond the expiration date of IRB approval. If continuing
review is not secured by the expiration date, the research must stop,
unless the IRB finds that it is in the best interests of individual subjects
to continue participating in the research interventions or interactions.
Instructions for completing and submitting the request to renew a protocol
are provided on the form. Please note
that if you do propose to change a protocol, there are two documents needed,
in addition to the form.
- A memo describing the changes.
- A modified version of the currently approved protocol highlighting
the changes in bold type.
|